The Advanced Research Projects Agency for Health, or ARPA-H, is looking for cities that can help design biomedical products, enhance clinical trials and bring new health products to market. Winning bidders would land hundreds of jobs.
Patricia Martin, the group’s president and CEO since 2019, last month announced she would step down to examine opportunities in the private sector and urged industry leaders to take a fresh look at the organization.
Ascension, the largest health system in central Indiana by number of beds, did not name a successor. It said in the announcement it “will be working through a thoughtful transition plan.”
The new law could allow utilities to pass along certain costs to customers for federally mandated projects without having to get pre-approval for those projects from state regulators.
Moody’s action pushed Elanco’s credit rating further into “junk bond” territory, an area considered riskier than investment-grade debt.
The National Institutes of Health awarded the grant to the Indiana Clinical and Translational Sciences Institute, a partnership among Indiana University, Purdue University and University of Notre Dame.
Fred Cate, IU’s vice president for research, informed federal officials that the research group had “a pattern of non-compliance” and had been warned several times against using expired materials.
Recovery Force Health said it plans to use the new funding as growth capital to market its device to hospitals and introduce other products.
A bill advancing through the Legislature would add natural gas to the list of clean-energy projects state utility regulators could consider for a financial incentive known as “construction work in progress,” or CWIP for short.
Eli Lilly said the study concludes its clinical development of solanezumab, apparently shutting the door on one of the most closely watched experimental drugs over the past decade.
The Weinberg Center for Corporate Governance at the University of Delaware, a leading voice for responsible corporate leadership, has generally supported the elimination of staggered terms, saying they can lead to entrenched boards and management that fails to perform.
Shares in the animal health care company have lost more than two-thirds of their value in the past 18 months, but Elanco says a bevy of new products in its pipeline will prove an era of strong growth is yet to come.
The Indianapolis-based drugmaker also said it will expand a program that caps patient out-of-pocket costs at $35 or less a month.
Five of the top 10 research studies that received the most NIH funding at the medical school were for Alzheimer’s disease or brain aging, one of the school’s top priorities.
IU Health said it responded to its highest patient demand ever last year, driven by surges in COVID-19 cases, high counts of critically ill patients, and the need to perform surgeries and other procedures delayed in the pandemic.
The Greenfield-based maker of animal medicines said fourth-quarter revenue fell due to “environmental and competitive pressure” and could continue to slip this year.
In January 2020, the federal government filed a lawsuit against Community Health Network, alleging the system engaged in a years-long scheme to recruit physicians and pay them huge salaries and bonuses in return for referrals. The two sides are still battling in court.
Many parts of downtown are thriving—particularly neighborhoods, where rents are rising, people have to stand in line for a lunch table, and investments are flowing. Other parts—especially downtown’s central core, where many workers might come to the office only once or twice a week—are limping along, pockmarked by vacant storefronts, panhandlers and crumbling sidewalks.
Cummins, Rolls-Royce, Eli Lilly and Co., AES and Elevance Health are among the city’s largest downtown employers and all say most of their workers have the option of working at home at least part of the time.
Patty Martin, president and CEO of BioCrossroads since 2019, said she plans to leave the organization to examine opportunities in the private sector.
